A new study found that dementia cases in the United States are projected to double from more than 500,000 in 2020 to about 1 million by 2050.

SEE ALSO | Lifestyle changes are key after study links Ozempic to lower Alzheimer's risk: Expert Clearing away snow and ...

Naturally, more work is needed. Although GLS -1 agonists have been used in diabetes for 20 years, some of the newer findings ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Now that Novo Nordisk is the world’s weight-loss juggernaut, will it have to betray its first patients—type 1 diabetics?

Stay updated on the latest potential FDA drug approvals in 2025, including an expanded label for Ozempic and new, nonopioid painkillers.

Eli Lilly & Co. (NYSE: LLY) is a major global pharmaceutical company in the medical sector. The company made headlines with ...

Tablet forms of semaglutide — better known as Ozempic, an injectable drug for weight-loss — are already in trials for Alzheimer’s and results are expected in late 2025. Mr Cummings ...

The condition is most commonly diagnosed in people in their 70s, but you can take steps before then to make your brain more ...

As drugs emerge as vital to the Government’s anti-obesity strategy, BBC Panorama is shedding light on the pharmaceuticals industry behind them ...